Skip to content
Press Release
FEATURED | September 11, 2025

Jason Chambers Headlines the Melanoma Research Fou...

Superyacht Captain, TV Personality, Melanoma Patient and Advocate Poised to Emcee Event Honoring the Melanoma Community  New York City, NY (September 11, 2025) – The...

4 Minute Read
December 23, 2024

Surveillance and Survivorship in Sentinel Lymph No...

Kelsey Montgomery’s Abstract Melanoma, an aggressive skin cancer, can spread cancer cells to nearby lymph nodes. When removing a melanoma, surgeons will often also re...

2 Minute Read
December 23, 2024

Metabolic Dependencies of Melanoma Brain Metastasi...

Afsaneh Amouzegar’s Abstract Melanoma is the most aggressive form of skin cancer. One of the most common and devastating complications of melanoma is the spread of ca...

2 Minute Read
December 23, 2024

Effects of Adjuvant Anti-PD1 on Atypical/Dysplasti...

Urvashi Joshi’s Abstract Melanoma is the fifth most common cancer in the U.S. Melanoma is an important public health concern and has a rising number of new cases and ...

2 Minute Read
December 23, 2024

Targeting EGFR in NF1 mutant melanoma

Milad Ibrahim’s Abstract Melanoma can be classified according to TCGA into 4 genetic subtypes: BRAF, NRAS, NF1 mutants or triple wild type. A lot of research focused ...

1 Minute Read
December 18, 2024

A gene regulatory network driving melanoma immune ...

Pietro Berico’s Abstract Prolonged sun exposure combined with other multi-factorial cues can transform skin’s melanocytes into melanoma cells characterized by uncon...

2 Minute Read
December 18, 2024

Effect of Microglia Type I IFN Response in Melanom...

Weili Ma’s Abstract When cancer cells metastasize to the brain, the diagnosis becomes terminal. In melanoma brain metastasis, patients are only given months to live. ...

2 Minute Read
December 18, 2024

UV-Induced Epigenetic Changes in the Epidermis in ...

Elena Ezhkova’s Abstract Melanoma is an aggressive type of skin cancer with a low survival rate when it metastasizes. Melanoma originates mainly in sun-exposed areas,...

2 Minute Read
December 18, 2024

ADAR1 Inhibitor: Novel Therapeutic for Melanoma &a...

Kazuko Nishikura’s Abstract The phenomenon of “RNA editing” is a relatively recent discovery with exciting implications. RNA editing is a process that modifies th...

3 Minute Read
December 18, 2024

Targeting PCBP2 to augment melanoma cell killing b...

Korbinian Kropp’s Abstract A major reason that T cell-based melanoma immunotherapies can fail, either initially or after a period of treatment, is due to mutations th...

2 Minute Read
December 18, 2024

Engaging the endogenous immune system with CAR T c...

Sarwish Rafiq’s Abstract Metastatic melanoma is one of the most aggressive, and complex cancers with a 35% 5-year survival rate. Therapies using T cells that are gene...

1 Minute Read
December 18, 2024

Complex Genomic Rearrangements Driving Sub-Clonal ...

Prashanthi Dharanipragada’s Abstract For decades, cancer initiation and progression are thought to occur gradually through small mutational changes in its DNA. After ...

2 Minute Read
February 24, 2024

SMR Young Investigator Award

SMR Young Investigator Award – Vito Rebecca, PhD

1 Minute Read

Oct 04, 2025 ET

Seattle Miles for Melanoma 5K

Oct 05, 2025 ET

Los Angeles Miles for Melanoma 5K

Oct 16, 2025 ET

Ask the Expert: Mucosal Melanoma – Current and Emerging Treatments, Research and Patient Perspectives

Oct 16, 2025 ET

5th Annual #GetNakedJax

Oct 18, 2025 ET

San Diego Miles for Melanoma 5K

Oct 25, 2025 ET

CURE OM Global Science Meeting

Oct 30, 2025 ET

Ask The Expert: Minimal Residual Disease Testing in Melanoma Management

Explore Events